Topical roflumilast formulation having improved delivery and plasma half-life | Patent Number 11819496

US 11819496 B2
Application Number18176601
Publication NumberUS 20230310397 A1
Pendency8 months, 25 days
Filled DateMar 1, 2023
Priority DateJun 7, 2017
Publication DateOct 5, 2023
Expiration DateJun 6, 2037
Inventor/ApplicantsDavid W. Osborne
Archie W. THURSTON, JR.
David W. OSBORNE
Bhaskar CHAUDHURI
ExaminesHOWELL, THEODORE R.
Art Unit1628
Technology Center1600
Assignments
Iplg Llp
Current
Arcutis Biotherapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.